What is Photofrin
Approved as Treatment by the FDAPorfimer sodium, also called Photofrin, is approved by the FDA for 3 uses including Non-Small Cell Lung Carcinoma and Non-Small Cell Lung Carcinoma .
When to interrupt dosageThe prescribed dose of Photofrin is contingent upon the indicated ailment, for instance Non-Small Cell Lung Carcinoma, Esophageal Cancer and Non-Small Cell Lung Carcinoma. The measure of dosage alters with respect to the method of delivery featured in the table beneath.
Photofrin Novel Uses: Which Conditions Have a Clinical Trial Featuring Photofrin?At present, 77 active trials are being conducted to assess the potential of Photofrin in the management of Non-Small Cell Lung Carcinoma, Esophageal Cancer and other Non-Small Cell Lung Carcinoma pathologies.
Patient Q&A Section about photofrinThese questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who makes PHOTOFRIN?
"The 'PHOTOFRIN' trademark is owned by Concordia Laboratories Inc. 'PHOTOFRIN' is distributed in the United States by Pinnacle Biologics Inc."
When was PHOTOFRIN approved?
"The photofrin, the first PDT reagent, was approved in 1993 for the bladder cancer treatment."
What is porfimer used to treat?
"What is Photofrin and how does it work? Photofrin is a cancer treatment drug. A light-activated compound, Photofrin is injected into a patient's bloodstream, where it travels to cancer cells and collects in these cells. When exposed to a certain wavelength of light, Photofrin causes the cancer cells to die."
What is PHOTOFRIN used for?
"The aim of PDT with PHOTOFRIN is to help improve the symptoms of patients with NSCLC who have a blocked airway, or when the cancer cannot be treated with laser alone. PHOTOFRIN is indicated to help reduce the symptoms of esophageal cancer when the cancer blocks the esophagus."